Dr. Shuang-En Chuang-Publication

PUBLICATIONS
  1. Chen CW, Tsai JFY, and Chuang SE. Intraplasmid recombination in Streptomyces lividans 66. Mol Gen Genet 1987, 209:154-158 .
  2. Aoki HA, Adams SL, Chung DG, Haguch M, Chuang SE, and Ganoza MC. Cloning, sequencing and overexpression of the gene for prokaryotic factor EF-P involved in peptide bond synthesis. Nucleic Acids Res 1991, 19:6215-6220 .
  3. Blattner FR, Daniels DL, Burland VD, Plunkett III G, and Chuang SE (1992). “The E. coli genome project: towards the first megabase.” pp 43-59, in: The Chromosome (John Innes Symposium, Norwich, England). J. S. Heslop-Harrison and R. B. Flavell (eds). Oxford, UK, Bios Scientific Publishers.
  4. Chuang SE, Daniels DL, and Blattner FR. Global regulation of gene expression in Escherichia coli. J Bacteriol 1993, 175:2026-2036.
  5. Chuang SE, and Blattner FR. Characterization of twenty-six new heat shock genes of Escherichia coli. J Bacteriol 1993, 175:5242-5252 .
  6. Chuang SE, Burland V, Plunkett III G, Daniels DL, and Blattner FR. Sequence analysis of four new heat-shock genes constituting the hslTS/ibpAB and hslVU operons in Escherichia coli. Gene 1993, 134:1-6 .
  7. Chuang SE, and Blattner FR. Ultrafast DNA recovery from agarose by centrifugation through a paper slurry. BioTechniques 1994, 17(4):634-636 .
  8. Chuang SE, Cheng AL, and Chao CC. Growth of E. coli at low temperature dramatically increases the transformation frequency by electroporation. Nucleic Acids Res. 1995, 23(9): 1641 .
  9. Chuang SE, Wang KC, and Cheng AL. Single-step direct cloning of PCR products. Trends in Genetics 1995, 11(1):7-8 .
  10. Lin MT, Chen YC, Chen PJ, Yang YC, Tang JL, Wu JM, Chuang SE, and Yang CS. Envelope gene sequences of human T-lymphotropic virus type I in Taiwan. Arch. 1996, Virol. 141:219-229.
  11. Cheng AL, Chen YC, Yeh KH, Chuang SE, Chen BR, and Chen DS. Chronic oral VP-16 and tamoxifen in the treatment of far-advanced hepatocellular carcinoma. Cancer, 1996, 77:872-877 .
  12. Kuo ML, Chen CW, Jee SH, Chuang SE, and Cheng AL. TGF-b1 attenuates ceramide-induced CPP32/Yama activation and apoptosis in human leukemic HL-60 cells. Biochem J. 1997, 327(3): 663-667 .
  13. Cheng AL, Chuang SE, and Su IJ. Factors associated with the therapeutic efficacy of retinoic acids on malignant lymphomas. J. Formos. Med. Assoc. 1997, 96(7): 525-534.
  14. Chuang SE, Doong SL, Lin MT, and Cheng AL. Tax of the human T-lymphotropic virus type I transactivates promoter of the MDR-1 gene. Biochem Biophys Res Commun. 1997, 238(2): 482-486.
  15. Chuang SE, and Yang CH. Biotherapy and gene therapy of cancers. Formos. J. Med. 1998, (台灣醫學) 2(3): 321-327.
  16. Cheng AL, Chuang SE, Fine RL, Yeh KH, Liao CM, Lay JD, and Chen DS. Inhibition of membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen. Biochem. Pharmacol. 1998, 55: 523-531.
  17. Cheng AL, Yeh KH, Fine RL, Chuang SE, Yang CH, Wang LH, and Chen DS. Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinoma. Hepatogastroenterol. 1998, 45(24):1955-1960.
  18. Kuo ML, Shen SC, Yang CH, Chuang SE, Cheng AL, and Huang TS. Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity. Oncogene 1998, 17(17): 2225-2234.
  19. Doong SL, Lin MH, Tsai MM, Li TR, Chuang SE, and Cheng AL. Transactivation of the human MDR1 gene by hepatitis B virus X gene product. J. Hepat. 1998, 29(6):872-878.
  20. Shiah SG, Chuang SE, Chau YP, Shen SC, and Kuo ML. Activation of c-Jun NH2-terminal kinase and subsequent CPP32/Yama during topoisomerase inhibitor beta-lapachone-induced apoptosis through an oxidation-dependent pathway. Cancer Res. 1999, 59(2):391-398 .
  21. Kuo ML, Shiah SG, Wang CJ, and Chuang SE. Suppression of apoptosis by bcl-2 to enhance benzene metabolites-induced oxidative DNA damage and mutagenesis: A possible mechanism of carcinogenesis. Mol. Pharmacol. 1999, 55(5):894-901.
  22. Chuang SE, and Blattner FR. Identification of phosphate-regulated genes by differential expression in the UV-irradiated host system. J. Microbiol. Methods. 1999, 37:93-96.
  23. Chuang SE, Kuo ML, Hsu CH, Chen CR, Lin JK, Lai GM, Hsieh CY, and Cheng AL. Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis. 2000 Feb; 21(2):331-335.
  24. Chuang SE, Cheng AL, Lin JK, and Kuo ML. Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats. Food Chem Toxicol. 2000 Nov 1;38(11):991-995.
  25. Shih WL, Kuo ML, Chuang SE, Cheng AL, and Doong SL. Hepatitis B virus X protein inhibits transforming growth factor-{beta}-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. J Biol Chem. 2000 Aug 18;275(33):25858-25864.
  26. Wang KC, Cheng AL, Chuang SE, Hsu H, and Su IJ. Retinoic acid-induced apoptotic pathway in T-cell lymphoma. Identification of four groups of genes with differential biological functions. Exp Hematol. 2000 Dec;28(12):1441-50.
  27. Shiah SG, Chuang SE, and Kuo ML. Involvement of Asp-Glu-Val-Asp-Directed, Caspase-Mediated Mitogen-Activated Protein Kinase Kinase 1 Cleavage, c-Jun N-Terminal Kinase Activation, and Subsequent Bcl-2 Phosphorylation for Paclitaxel-Induced Apoptosis in HL-60 Cells. Mol Pharmacol 2001 Feb;59(2):254-262.
  28. Kuo ML, Chuang SE, Lin MT, and Yang SY. The involvement of PI 3-K/Akt-dependent up-regulation of Mcl-1 in the prevention of apoptosis of Hep3B cells by interleukin-6. Oncogene. 2001 Feb 8;20(6):677-685.
  29. Yeh PY, Chuang SE, Yeh KH, Song YC, and Cheng AL. Nuclear extracellular signal-regulated kinase 2 phosphorylates p53 at Thr55 in response to doxorubicin. Biochem Biophys Res Commun. 2001 Jun 22;284(4):880-886.
  30. Hsu CH, Hergenhahn M, Chuang SE, Yeh PY, Wu TC, Gao M, and Cheng AL. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin. Anticancer Res. 2002 Nov-Dec;22(6C):4065-4071.
  31. Chuang SE, Yeh PY, Lu YS, Lai GM, Liao CM, Gao M, and Cheng AL. Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells. Biochem Pharmacol. 2002 May 1;63(9):1709-1716.
  32. Yeh PY, Chuang SE, Yeh KH, Song YC, Ea CK, and Cheng AL. Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NF kappa B activation. Biochem Pharmacol. 2002 Apr 15;63(8):1423-1430.
  33. Hsu CH, Chuang SE, Hergenhahn M, Kuo ML, Lin JK, Hsieh CY, and Cheng AL. Pre-clinical and early-phase clinical studies of curcumin as chemopreventive agent for endemic cancers in Taiwan. Gan To Kagaku Ryoho. 2002 Feb;29 Suppl 1:194-200.
  34. Lay JD, Chuang SE, Rowe M, and Su IJ. Epstein-barr virus latent membrane protein-1 mediates upregulation of tumor necrosis factor-alpha in EBV-infected T cells: implications for the pathogenesis of hemophagocytic syndrome. J Biomed Sci. 2003 Jan-Feb;10(1):146-155.
  35. Shih WL, Kuo ML, Chuang SE, Cheng AL, and Doong SL. Hepatitis B virus X protein activates a survival signaling by linking SRC to phosphatidylinositol 3-kinase. J Biol Chem. 2003 Aug 22;278(34):31807-31813.
  36. Yeh PY, Chuang SE, Yeh KH, Song YC, and Cheng AL. Involvement of nuclear transcription factor-kappa B in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells. Biochem Pharmacol. 2003 Jul 1;66(1):25-33.
  37. Yeh PY, Chuang SE, Yeh KH, Song YC, Chang LL, and Cheng AL. Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death. Oncogene. 2004 Apr 29;23(20):3580-3588.
  38. Yeh PY, Yeh KH, Chuang SE, Song YC, and Cheng AL. Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-kappaB activation by protein phosphatase 4-mediated NF-kappaB p65 Thr dephosphorylation. J Biol Chem. 2004 Jun 18;279(25):26143-26148.
  39. Pu YS, Hour TC, Chuang SE, Cheng AL, Lai MK, and Kuo ML. Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells. Prostate. 2004 July 1;60(2):120-129.
  40. Yan MD , Hong CC, Lai GM, Cheng AL, Lin YW, Chuang SE*. Identification and characterization of a novel gene Saf transcribed from the opposite strand of Fas. Hum Mol Genet., 2005 June 1;14(11):1465-1474.
  41. Chuang HC, Lay JD, Hsieh WC, Wang HC, Chang Y, Chuang SE, and Su IJ. Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome. Blood. 2005 Nov 1;106(9):3090-3096.
  42. Yao CJ, Lai GM, Chan CF, Yang YY, Liu F, and Chuang SE*. Differentiation of pheochromocytoma PC12 cells induced by human urine extract and the involvement of the extracellular signal-regulated kinase signaling pathway. J Altern Complement Med. 2005 Oct;11(5):903-8.
  43. Yao CJ, Lai GM, Chan CF, Cheng AL, Yang YY, and Chuang SE*. Dramatic synergistic anticancer effect of clinically achievable doses of lovastatin and troglitazone. Int J Cancer. 2006 Feb 1;118(3):773-779.
  44. Yeh PY, Kuo SH, Yeh KH, Chuang SE, Hsu CH, Chang WC, Lin HI, Gao M, and Cheng AL. A pathway for TNFalpha-induced Bcl10 nuclear translocation: Bcl10 is upregulated by NFkappa B, phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus. J Biol Chem. 2006 Jan 6;281(1):167-175.
  45. Lu YS, Yeh PY, Chuang SE, Gao M, Kuo ML, and Cheng AL. Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-kB activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa. J Endocrinol. 2006 Feb;188(2):311-319.
  46. Chen CN, Huang HH, Wu CL, Lin PC, Hsu TA, Hsieh HP, Chuang SE, and Lai GM. Isocostunolide, a sesquiterpene lactone, induces mitochondrial membrane depolarization and caspase-dependent apoptosis in human melanoma cells. Cancer Lett. 2007 246: 237-252.
  47. Su JL, Yen CJ, Chen PS, Chuang SE, Hong CC, Kuo IH, Chen HY, Hung MC, and Kuo ML. The role of the VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer. 2007 Feb 26;96(4):541-545.
  48. Lay JD, Hong CC, Huang JS, Yang YY, Pao CY, Liu CH, Lai YP, Lai GM, Cheng AL, Su J, and Chuang SE*. Sulfasalazine Suppresses Drug Resistance and Invasiveness of Lung Adenocarcinoma Cells Expressing AXL. Cancer Res. 2007 Apr 15;67(8):3878-3887.
  49. Chuang HC, Lay JD, Chuang SE, Hsieh WC, Chang Y, and Su IJ. Epstein-Barr Virus (EBV) Latent Membrane Protein-1 Down-Regulates Tumor Necrosis Factor-a (TNF-a) Receptor-1 and Confers Resistance to TNF-a -Induced Apoptosis in T Cells: Implication for the Progression to T-Cell Lymphoma in EBV-Associated Hemophagocytic Syndrome. Am J Pathol. 2007 May;170(5):1607-1617.
  50. Chen PS, Wang MY, Wu SN, Su JL, Hong CC, Chuang SE, Chen MW, Hua KT, Wu YL, Cha ST, Babu MS, Chen CN, Lee PH, Chang KJ, and Kuo ML. CTGF enhances the motility of breast cancer cells via an integrin-{alpha}vbeta3-ERK1/2-dependent S100A4-upregulated pathway. J Cell Sci. 2007 Jun 15;120(Pt 12):2053-2065.
  51. Huang WJ, Huang CH, Wu CL, Lin JK, Chen YW, Lin CL, Chuang SE, Huang CY, and Chen CN. Propolin G, a Prenylflavanone, Isolated from Taiwanese Propolis, Induces Caspase-Dependent Apoptosis in Brain Cancer Cells. J Agric Food Chem. 2007 Sep 5;55(18):7366-7376.
  52. Kao YH, Hsieh HP, Chitlimalla SK, Pan WY, Kuo CC, Tsai YC, Lin WH, Chuang SE*, and Chang JY*. A novel peroxisome proliferator-activated receptor alpha/gamma agonist, BPR1H0101, inhibits topoisomerase II catalytic activity in human cancer cells. Anticancer Drugs. 2008 Feb;19(2):151-158.
  53. Dai HY, Hong CC, Liang SC, Yan MD, Lai GM, Cheng AL, and Chuang SE*. Carbonic anhydrase III promotes transformation and invasion capability in hepatoma cells through FAK signaling pathway. Mol Carcinog. 2008 Dec;47(12):956-963.
  54. Hong CC, Lay JD, Huang JS, Cheng AL, Tang JL, Lin MT, Lai GM, and Chuang SE*. Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia. Cancer Lett. 2008 Sep 18;268(2):314-24.
  55. Yeh CT, Rao YK, Yao CJ, Yeh CF, Li CH, Chuang SE, Luong JH, Lai GM, and Tzeng YM. Cytotoxic triterpenes from Antrodia camphorata and their mode of action in HT-29 human colon cancer cells. Cancer Lett. 2009 Nov 18;285:73-9.
  56. Yan KH, Yao CJ, Chang HY, Lai GM, Cheng AL, and Chuang SE*. The synergistic anticancer effect of troglitazone combined with aspirin in lung cancer cells. Mol Carcinog. 2010 Mar;49(3):235-46.
  57. Yao CJ, Yang CM, Chuang SE, Yan JL, Liu CY, Chen SW, Yan KH, Lai TY, Lai GM. Targeting PML-RARα and Oncogenic Signaling Pathways by Chinese Herbal Mixture Tien-Hsien Liquid in Acute Promyelocytic Leukemia NB4 Cells. Evid Based Complement Alternat Med. 2011; 2011:984154.
  58. Yeh CT, Yao CJ, Yan JL, Chuang SE, Lee LM, Chen CM, Yeh CF, Li CH, Lai GM. Apoptotic Cell Death and Inhibition of Wnt/β-Catenin Signaling Pathway in Human Colon Cancer Cells by an Active Fraction (HS7) from Taiwanofungus camphoratus. Evid Based Complement Alternat Med. 2011; 2011:750230.
  59. Hsu HY, Lin JH, Li CJ, Tsang SF, Tsai CH, Chyuan JH, Chiu SJ, Chuang SE*. Antimigratory Effects of the Methanol Extract from Momordica charantia on Human Lung Adenocarcinoma CL1 Cells. Evid Based Complement Alternat Med. 2012; 2012:819632.
  60. Yao CJ, Yeh CT, Lee LM, Chuang SE, Yeh CF, Chao WJ, Lai TY, Lai GM. Elimination of cancer stem-like “side population” cells in hepatoma cell lines by chinese herbal mixture “tien-hsien liquid”. Evid Based Complement Alternat Med. 2012; 2012:617085.
  61. Huang WJ, Liang YC, Chuang SE, Chi LL, Lee CY, Lin CW, Chen AL, Huang JS, Chiu CJ, Lee CF, Huang CY, Chen CN. NBM-HD-1: A Novel Histone Deacetylase Inhibitor with Anticancer Activity. Evid Based Complement Alternat Med. 2012; 2012:781417.
  62. Huang JS, Cho CY, Hong CC, Yan MD, Hsieh MC, Lay JD, Lai GM, Cheng AL, Chuang SE*. Oxidative stress enhances Axl-mediated cell migration through an Akt1/Rac1-dependent mechanism. Free Radic Biol Med. 2013 Dec;65:1246-56.
  63. Yan KH, Lee LM, Hsieh MC, Yan MD, Yao CJ, Chang PY, Chen TL, Chang HY, Cheng AL, Lai GM, Chuang SE*. Aspirin antagonizes the cytotoxic effect of methotrexate in lung cancer cells. Oncol Rep. 2013 Sep; 30(3):1497-505.
  64. Yan KH, Yao CJ, Hsiao CH, Lin KH, Lin YW, Wen YC, Liu CC, Yan MD, Chuang SE, Lai GM, Lee LM. Mefloquine exerts anticancer activity in prostate cancer cells via ROS-mediated modulation of Akt, ERK, JNK and AMPK signaling. Oncol Lett. 2013 May; 5(5):1541-1545.
  65. Yan KH, Lin YW, Hsiao CH, Wen YC, Lin KH, Liu CC, Hsieh MC, Yao CJ, Yan MD, Lai GM, Chuang SE, Lee LM. Mefloquine induces cell death in prostate cancer cells and provides a potential novel treatment strategy in vivo. Oncol Lett. 2013 May; 5(5):1567-1571.
  66. Yao CJ, Lai GM, Yeh CT, Lai MT, Shih PH, Chao WJ, Whang-Peng J, Chuang SE, Lai TY. Honokiol Eliminates Human Oral Cancer Stem-Like Cells Accompanied with Suppression of Wnt/ β -Catenin Signaling and Apoptosis Induction. Evid Based Complement Alternat Med. 2013; 2013:146136.
  67. Fucoidan Elevates MicroRNA-29b to Regulate DNMT3B-MTSS1 Axis and Inhibit EMT in Human Hepatocellular Carcinoma Cells. Yan MD, Yao CJ, Chow JM, Chang CL, Hwang PA, Chuang SE, Whang-Peng J, Lai GM. Mar Drugs. 2015 Sep 24; 13(10):6099-116.
  68. Lai IC, Shih PH, Yao CJ, Yeh CT, Wang-Peng J, Lui TN, Chuang SE, Hu TS, Lai TY, Lai GM. Elimination of cancer stem-like cells and potentiation of temozolomide sensitivity by Honokiol in glioblastoma multiforme cells. PLoS One. 2015 Mar 12; 10(3):e0114830.
  69. Yao CJ, Chow JM, Yang CM, Kuo HC, Chang CL, Lee HL, Lai IC, Chuang SE, Lai GM. Chinese Herbal Mixture, Tien-Hsien Liquid, Induces G2/M Cycle Arrest and Radio-sensitivity in MCF-7 Human Breast Cancer Cells through Mechanisms Involving DNMT1 and Rad51 Downregulation. Evid Based Complement Alternat Med. 2016; 2016: 3251046.
  70. Huang JS, Yao CJ, Chuang SE, Yeh CT, Lee LM, Chen RM, Chao WJ, Whang-Peng J, Lai GM. Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction. BMC Cancer. 2016 Mar 24; 16(1):245.
  71. Cho CY, Huang JS, Shiah SG, Chung SY, Lay JD, Yang YY, Lai GM, Cheng AL, Chen LT, Chuang SE*. Negative feedback regulation of AXL by miR-34a modulates apoptosis in lung cancer cells. RNA. 2016 Feb; 22(2):303-15.
  72. Yen SY, Chen SR, Hsieh J, Li YS, Chuang SE, Chuang HM, Huang MH, Lin SZ, Harn HJ, Chiou TW. Biodegradable interstitial release polymer loading a novel small molecule targeting Axl receptor tyrosine kinase and reducing brain tumour migration and invasion. Oncogene. 2016 Apr 28; 35(17): 2156-65.
  73. Yao CJ, Chuang SE, Yang YY, Lai GM. Human Urine Extract CDA-2 Protects PC12 Cells from Serum Deprivation-Induced Apoptosis Accompanied with Priming of ERK Activation and Differentiation Induction. Chinese Journal of Integrative Medicine. (in press)
  74. Yao CJ, Chow JM, Yang CM, Kuo HC, Chang CL, Lee HL, Lai IC, Chuang SE, Lai GM. Chinese Herbal Mixture, Tien-Hsien Liquid, Induces G2/M Cycle Arrest and Radiosensitivity in MCF-7 Human Breast Cancer Cells through Mechanisms Involving DNMT1 and Rad51 Downregulation. Evid Based Complement Alternat Med. 2016; 2016: 3251046.
  75. Yao CJ, Chow JM, Chuang SE, Chang CL, Yan MD, Lee HL, Lai IC, Lin PC, Lai GM. Induction of FOXO3a and apoptosis by a standardized ginsenoside formulation KG135 is potentiated by autophagy blockade in A549 human lung cancer cells. Journal of Ginseng Research 2017 Jul; 41(3): 247-256.
  76. Cho CY, Chung SY, Lin SK, Huang JS, Chen YL, Cheng LC, Hsiang KT, Lay JD, Yang YY, Lai GM, and Chuang SE*. PTBP1-mediated regulation of AXL mRNA stability plays a role in lung tumorigenesis (Oncotarget, in revision, 2017)

MEETING ABSTRACTS :

  1. Cheng AL, Yeh KH, Luo YJ, Chuang SE, and Chen DS. Synergistic effect of doxorubicin and tamoxifen in the treatment of hepatocellular carcinoma (HCC): in vitro and pilot clinical study. Proc Am Assoc Cancer Res, 1995, 36: 347.
  2. Chuang SE, Lin CH, Luo YJ, and Cheng AL. The tax gene product of the human lymphotropic virus HTLV-1 transactivates promoter of the mdr-1 gene. Proc Am Assoc Cancer Res, 1996, 37: 78.
  3. Chuang SE, Cheng AL, Kuo ML, and Hsieh CY. Curcumin decreases the level of proliferation cellular nuclear antigen (PCNA), and retards the process of diethylnitrosamine (DEN)-induced mouse hepatocarcinogenesis. Proc Am Assoc Cancer Res, 1997, 38: 370.
  4. Chuang SE. Chemoprevention of chemical-induced murine HCC by curcumin. The 2nd German-Taiwanese Workshop on Tumor Prevention, Taipei, 1997.
  5. Cheng AL, Chuang SE, Lai GM, Liao CM, and Hsieh CY. Universal activation of NF-kB by anticancer drugs in cancer cell lines. Proc Am Assoc Cancer Res, 1998, 39: 215.
  6. Yeh KH, Cheng AL, Yeh SH, Ma IF, Wang KC, Lin JT, Chuang SE, and Lin JK. Bcl-2 transfection confers multidrug resistance to gastric cancer cells. Proc Am Assoc Cancer Res, 1998, 39: 570.
  7. Chuang SE, Lai GM, and Cheng AL. A novel variant transcript of the human Fas/Apo-1 gene. Proc Am Assoc Cancer Res, 1998, 39: 453.
  8. Chuang SE. Chemoprevention of hepatocellular carcinoma (HCC): Current status and future perspectives. The 13th Joint Annual Conference of Biomedical Sciences, Taipei, Taiwan, 1998, P. s31.
  9. Chuang SE, Tang JL, Lin MT, Chen JW, Peck K, Chou MH, Lai GM, and Cheng AL. Cloning of genes differentially expressed in the drug-sensitive and drug-resistant leukemia cells. Proc Am Assoc Cancer Res, 1999, 40: 426.
  10. Yeh PY, Chuang SE, Song YC, and Cheng AL. Interaction of ERK2 and p53 in doxorubicin treated human cervical carcinoma cells. Proc Am Assoc Cancer Re, 1999s, 40: 96.
  11. Yeh PY, Chuang SE, Song YC, and Cheng AL. Doxorubicin induces a MEK-independent suppression of ERK activity in a human cervical carcinoma cell line. Proc Am Assoc Cancer Res, 1999, 40: 580.
  12. Lu YS, Hsieh CY, Chuang SE, Yeh PY, and Cheng AL. Glucocorticoids enhance the cytotoxicity of cisplatin in a human cervical carcinoma cell line. Proc Am Assoc Cancer Res, 1999, 40: 16.
  13. Lai GM, Liu FC, Chen YF, Hsieh CW, Cha’ng HJ, and Chuang SE. Induction of differentiation and apoptosis in human leukemia (HL-60) cells by human urine extracts (CDA-2) and augmented by all0trans retinoic acid. Proc Am Assoc Cancer Re, 1999s, 40: 62.
  14. Ch’ang HJ, Chuang SE, Liu FC, Chen YF, Hsieh CW, and Lai GM. Potentiation of taxol cytotoxicity by human urine extract in MCF7/ADR cells. Proc Am Assoc Cancer Res, 1999, 40: 664.
  15. Shih WL, Chuang SE, Cheng AL, and Doong SL. Inhibition of TGF-b-induced Apoptosis by Hepatitis B Virus X Protein. 1999 Aug 8th International Symposium of Society of Chinese Bioscientists in America, Hong Kong Convention and Exhibition Center, Hong Kong, China.
  16. Shih WL, Chuang SE, Cheng AL, and Doong SL. Inhibition of TGF-b-induced Apoptosis by Hepatitis B Virus X Protein. 1999 April 第四屆臺灣癌症聯合學術年會。
  17. Chen YF, Hsieh CW, Chuang SE, Liu CC, Chlang HJ, and Lai GM. A role for the Mek/MAPK pathway in human-urine-extract-induced cell growth arrest: Modulation of differentiation of HL-60 cells.. Proc Am Assoc Cancer Res, 2000, 41: 758.
  18. Yeh PY, Chuang SE, Song YC, Ea CK, and Cheng AL. Suppression of Mek/Erk activity is associated with sisplatin resistance in human cervical carcinoma cell. Proc Am Assoc Cancer Res, 2000, 41: 180.
  19. Chuang SE, Hong CC, Lai GM, and Cheng AL. Construction of directional cDNA libraries from trace amounts of total RNA. Proc Am Assoc Cancer Res, 2000, 41: 857.
  20. Hong CC, Cheng AL, Lai GM and Chuang SE. A robust method of protein tyrosine kinase profiling for the drug-sensitive and drug-resistant leukemic cells. The 5th Taiwan Joint Cancer Conference, 2000, p45.
  21. Chen YF, Chuang SE, Hsieh CW, Liu CC, Hong CC, Ch’ang HJ, and Lai GM. Synergistic induction of differentiation but not apoptosis by CDA-2 and arsenic trioxide in NB4 cells. The 5th Taiwan Joint Cancer Conference, 2000, p49.
  22. Lai GM, Wu MF, Liu CC, Chen YF, Han CH, Ch’ang HJ, Lai JD, Yao CJ, Hong CC, and Chuang SE. Human urine extracts (CDA-2) as novel antitumor and chemopreventive agent for human hepatoma cells (Smmu 7721) in SCID mice model. The 5th Taiwan Joint Cancer Conference, 2000, p58.
  23. Lai JD, Chuang SE, Lai GM, Rowe M, and Su IJ. Upregulation of tumor necrosis factor-a gene by Epstein-Barr virus (EBV) signal transducer LMP1 in EBV-infected T cell disorders. The 5th Taiwan Joint Cancer Conference, 2000, p59.
  24. Yeh PY, Chuang SE, Song YC, and Cheng AL. A single low-dose doxorubicin results in heritable change of basal NF0kB, inducible ERK2 activity, and parallel drug resistance. The 5th International Conference of the Asian Clinical Oncology Society (ACOS) & The 6th Taiwan Joint Cancer Conference, Taipei, Taiwan, 5-8 April, 2001, Proceedings, p67.
  25. Lu YS, Yeh PY, Chuang SE, Yeh KH, Yang CH, and Cheng AL. Glucocorticoids affect growth and chemosensitivity of carcinoma cells via diverse glucocorticoid receptor-dependent pathways. The 5th International Conference of the Asian Clinical Oncology Society (ACOS) & The 6th Taiwan Joint Cancer Conference, Taipei, Taiwan, 5-8 April, 2001, Proceedings, p68.
  26. Hsu CH, Hergenhahn M, Chuang SE, Yeh PY, Lin CJ, Chao NW, and Cheng AL. Epstein-Barr Virus (EBV) reactivation induced by anticancer drugs in B-lymphoid cells. The 5th International Conference of the Asian Clinical Oncology Society (ACOS) & The 6th Taiwan Joint Cancer Conference, Taipei, Taiwan, 5-8 April, 2001, Proceedings, p145.
  27. Yao CJ, Lai GM, Chan CF, Lay JD, Hong CC, Liu CC, and Chuang SE. Modulation of mitochondrial and NF-kB functions during human urine extract CDA-2 induced apoptosis in human hepatocellular carcinoma cells. The 5th International Conference of the Asian Clinical Oncology Society (ACOS) & The 6th Taiwan Joint Cancer Conference, Taipei, Taiwan, 5-8 April, 2001, Proceedings, p96.
  28. Chan CF, Chuang SE, Liu CC, Chen CH, Hong CC, Yao CJ, and Lai GM. Synergistic induction of HL-60 cell differentiation by CDA-2 and 1,25-dihydroxyvitamin D3. The 5th International Conference of the Asian Clinical Oncology Society (ACOS) & The 6th Taiwan Joint Cancer Conference, Taipei, Taiwan, 5-8 April, 2001, Proceedings, p96.
  29. Hsu CH, Hergenhahn M, Chuang SE, Yeh PY, Lin CJ, Chao NW, and Cheng AL. Epstein-Barr Virus (EBV) Reactivation Induced by Anticancer Drugs in B-Lymphoid Cells. Proc Am Assoc Cancer Res, 2001, 42: 111. #601
  30. Lu YS, Yeh PY, Chuang SE, and Cheng AL. Glucocorticoids Affect Growth and Chemosensitivity of Carcinoma Cells via Diverse Glucocorticoids Receptor-Dependent Pathways. Proc Am Assoc Cancer Res, 2001, 42: 549. #2951
  31. Yeh PY, Chuang SE, Song YC, Sun SW, and Cheng AL. A Single Low-Dose Doxorubicin Results in Heritable Change of Basal NFkB, Inducible ERK2 Activity, and Parallel Drug Resistance. Proc Am Assoc Cancer Res, 2001, 42: 928.#4982
  32. Chan CF, Chuang SE, Liu F, Chen C, Hong CX, Yao CJ, and Lai GM. Synergistic Induction of HL 60 Cell Differentiation by CDA-2 and 1,25-Dihydroxyvitamin D3. Miami, Florida, USA, October 29-November 2, 2001 AACR-NCI-EORTC International Conference, abstract#359.
  33. Lai GM, Chan CF, YaoCJ, Liu F, Chuang SE, Kao S, and Liau M. Potentiation of CDA-2 induced differentiation and apoptosis by antioxidants and nutraceuticals (Cryptomonadales). Miami, Florida, USA, October 29-November 2, 2001 AACR-NCI-EORTC International Conference, abstract#361.
  34. Yao CJ, Lai GM, Chan CF, and Chuang SE. Modulation of mitochondrial and NF-kB functions during human urine extract CDA-II induced apoptosis in human hepatocellular carcinoma cells. Miami, Florida, USA, October 29-November 2, 2001 AACR-NCI-EORTC International Conference, abstract#310.
  35. Shih WL, Chuang SE, Cheng AL, and Doong SL. Hepatitis B Virus X Protein Inhibits Transfroming Growth Factor-b-induced Apoptosis through the Activation of Phosphatidylinositol 3-Kinase Pathway. 2001/2 3rd NHRI Conference on Viral Hepatitis and Hepatocellular Carcinoma.
  36. Shih WL, Chuang SE, Cheng AL, and Doong SL. Hepatitis B Virus X Protein Activates a Survival Signaling by Linking Src to Phosphatidylinositol 3-Kinase. 2001/7 The 8th East Asian Joint Symposium on Biomedical Research.
  37. Gao M, Yeh PY, Chuang SE, Yeh KH, Song YC, and Cheng AL. Suppression of the MEK/ERK pathway enhances cisplatin-induced NFkB activation via upregulation of protein phosphatase X and dephosphorylatiom of NFkB p65. Proc Am Assoc Cancer Res, 2002, 43: 421.#2093.
  38. Lu YS, Yeh PY, Chuang SE, and Cheng AL. Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-kB activation in a receptor-rich human carcinoma cells. Proc Am Assoc Cancer Res, 2002, 43: 436.#2164.
  39. Chan CF, Chen CH, Liu CC, Liu CH, Yao CJ, Lai JD, Chuang SE, and Lai GM. CDA-2 and enhancement of growth arrest and differentiation of HL060 cells initiated by 1,25-dihydroxyvitamin D3. The 7th Taiwan Joint Cancer Conference, Taipei, Taiwan, 4-5 May, 2003.
  40. Chen CH, Chan CF, Liu CC, Liu CH, Yao CJ, Lai JD, Chuang SE, and Lai GM. CDA-2 and genes involved in regulation of cell differentiation in HL060. The 7th Taiwan Joint Cancer Conference, Taipei, Taiwan, 4-5 May, 2003.
  41. Yao CJ, Lai GM, Yang YY, Chan CF, Lai JD, and Chuang SE. Anti-apoptotic and cytotoxic properties of human urine extract CDA-2 in PC12 cells. The 7th Taiwan Joint Cancer Conference, Taipei, Taiwan, 4-5 May, 2003.
  42. Yeh PY, Chuang SE, Yeh KH, Song YC, Chang LY, and Cheng AL. Thr55 phosphorylation by ERK2 is related to doxorubicin-induced p53 activation and cellular apoptosis. Proc Am Assoc Cancer Res, 2003, 44: 754.#3300.
  43. Hsu CH, Gao M, Chuang SE, Yeh PY, Hsieh HY, and Cheng AL. Overexpression of Zta, a transactivator of Epstein-Barr virus (EBV), confers multi-drug resistance in NPC cells in vitro. Proc Am Assoc Cancer Res, 2003, 44: 1183.#5163.
  44. Lu YS, Yeh PY, Gao M, Chuang SE, and Cheng. Glucocorticoids (GC) enhance p21 expression and induce G1phase cell cycle arrest in MCF-7 cells – the possible role of GCreceptors and their co-regulator. Proc Am Assoc Cancer Res, 2004, vol. 45: #438.
  45. Kao WY, Wu JC, Chen WT, Chen WH, Chuang SE, and Yan HC. ERK and JNK coordinate bFGF-mediated cadherin down-regulation on human umbilical vein endothelial cells. Proc Am Assoc Cancer Res, 2005, vol. 46: #2023.
  46. Yeh PY, Kuo SH, Yeh KH, Chuang SE, Chang WC, and Cheng AL. Bcl10 is phosphorylated by Akt1 and then complexes with Bcl3 for nuclear translocaion and regulation of NF-κB transactivation activity. Proc Am Assoc Cancer Res, 2005, vol. 46: #1008.
  47. Yan MD, Hong CC, Lai GM, Cheng AL, Lin YW, and Chuang SE*. Identification and characterization of a novel gene Saf transcribed from the opposite strand of Fas. 台灣生物化學及分子生物學學會(The Taiwan Society of Biochemistry and Molecular Biology)-94年宜蘭夏令營 (2005年9月8~9日,國立宜蘭大學國際會議廳) poster#39.
  48. Yang YY, Yao CJ, Lai GM, Chan CF, Cheng AL, and Chuang SE*. Dramatic synergistic anticancer effect of clinically achievable doses of lovastatin and troglitazone. 台灣生物化學及分子生物學學會(The Taiwan Society of Biochemistry and Molecular Biology)-94年宜蘭夏令營 (2005年9月8~9日,國立宜蘭大學國際會議廳) poster#83.
  49. Dai HY, Liang SC and Chuang SE*. The Role of carbonic anhydrase III in hepatocarcinogenesis. 中華實驗動物學會會員大會研討會(2005年11月24-25日於中央研究院生物醫學研究所)
  50. Chen CN, Huang HH, Wu CL, Lin PC, Hsu TA, Chuang SE, and Lai GM. Isocostunolide, a sesquiterpene lactone, induces mitochondrial membrane depolarization and caspase-dependent apoptosis in human melanoma cells. The 11th Taiwan Joint Cancer Conference, Taipei, Taiwan, 6-7 May, 2006. Abstract A-1-7, p90.
  51. Chen CN, Huang HH, YehCF, Liu CY, Chuang SE, and Lai GM. Isocostunolide and dehydrocostus lactone, two sesquiterpene lactones, markedly inhibit cell growth through cell cycle regulation and apoptosis induction in human breast cancer MCF-7 and MDA-MB-231 cells. The 11th Taiwan Joint Cancer Conference, Taipei, Taiwan, 6-7 May, 2006. Abstract A-1-9, p92.
  52. Lai GM, Yao CJ, Yeh CF, Liu CY, Chen CN, Huang HH, and Chuang SE. CDA-2 radiosensitizes rat C6 glioma cells through inhibition of expression of Rad51 and phosphorylation of platelet-derived growth factor receptor. The 11th Taiwan Joint Cancer Conference, Taipei, Taiwan, 6-7 May, 2006. Abstract A-1-10, p93.
  53. Yao CJ, Chuang SE*, Chan CF, Yang YY, Yeh, CF and Lai GM. Synergistic growth inhibition of glioma cells by the combination of differentiation agent CDA-2 and lovastatin. The 11th Taiwan Joint Cancer Conference, Taipei, Taiwan, 6-7 May, 2006. Abstract A-1-11, p94.
  54. Yeh CF, Chen CN, Liu CY, Yao CJ, Chan CF, Chuang SE, Hsu TA, and Lai GM. PPAR activation and induction of differentiation or apoptosis in cancer cells by compounds purified from CDA-2. The 11th Taiwan Joint Cancer Conference, Taipei, Taiwan, 6-7 May, 2006. Abstract A-1-12, p95.
  55. Chen CN, Huang HH, Tsao CY, Chuang SE, and Lai GM. Isocostunolide, a sesquiterpene lactone, induces G2/M arrest and apoptosis in human colon carcinoma HT-29 cells. The 11th Taiwan Joint Cancer Conference, Taipei, Taiwan, 6-7 May, 2006. Abstract A-1-16, p99.
  56. Yao CJ, Chuang SE, Yeh CF, Yang CM, Lai GM. Human urine extract-mediated inhibition of irradiation-inducible molecular signals and enhancement of C6 glioma cell radiosensitivity. Everlife Biotechnology Ltd./Incubator of National Health Research Institutes, Taipei, Taiwan, National Institute of Cancer Research, National Health Research Institutes, Taipei, Taiwan . Proc Am Assoc Cancer Res, 2007, vol. 48: #3115.
  57. Dai HY, Hong CC, Liang SC, Lin YW, Lai GM, Cheng AL, and Chuang SE*. Carbonic anhydrase III promotes transformation and invasion capability in hepatoma cells through FAK signal pathway. The 1st International Cancer Symposium in CMU&H. Taichung, Taiwan, 16-17 October, 2007. Abstract 1-39, p84. (中國醫藥大學暨附設醫院第一屆國際癌症學術研討會)
  58. Yeh CT, Yao CJ, Chuang SE, Chang CK, Yeh CF, and Lai GM. Elimination of cancer stem-like “side population” cells existed in hepatoma cells by Chinese herbal mixture Tien-Hsien Liquid. The 1st International Cancer Symposium in CMU&H. Taichung, Taiwan, 16-17 October, 2007. Abstract 3-22, p118. (中國醫藥大學暨附設醫院第一屆國際癌症學術研討會)
  59. Yeh CT, Yao CJ, Chang CK, Yeh CF, Li CH, Yan JL, Chuang SE, and Lai GM. Elimination and epigenetic modification of cancer stem-like “side population” cells in hepatoma cell lines by human urine extract CDA-2. National Institute of Cancer Research, National Health Research Institutes, Taipei, Taiwan, Everlife Biotechnology Ltd./Incubator of National Health Research Institutes, Taipei, Taiwan, National Institute of Cancer Research, National Health Reserch Institutes, Taipei, Taiwan. Proc Am Assoc Cancer Res, 2008, vol. 49: #4592.
  60. 顏建隆, 李奇翰, 盧弘捷, 甘魯生, 姚智榮, 葉鵑鳳, 莊雙恩, 賴基銘. Purification and Characterization of Anticancer Active Triterpenoids from the ruiting Body of Taiwanofungus camphorates. The 23rd Joint Annual Conference of Biomedical Sciences (2008). 第23屆生物醫學聯合學術年會 (97年度), NDMC (國防醫學院), Taipei, Taiwan, 29-30 March, 2008. Poster #P51.
  61. 石光中, 莊雙恩, 顏明德, 陳涵栩, 郭清輝, 胡啟民, 何橈通. 瘦素和其受器在果糖餵食鼠所誘發慢性高胰島素血症之角色. 中華民國內分泌暨糖尿病學會2008年學術年會, NDMC (國防醫學院), Taipei, Taiwan, 01-02 March, 2008. #DO3-3.
  62. Yao CJ, Yeh CF, Yan JL, Li CH, Yeh CT, Chuang SE, and Lai GM. Active Fraction of Cultivated Antrodia Camphorata Fruiting Body-Induced Multi-Molecular Targeting Anticancer Effects on CL1-0 Human Lung Adenocarcinoma Cells. The 13th Taiwan Joint Cancer Conference. May 3-4, 2008. (第十三屆台灣癌症聯合學術年會暨第六屆海峽兩岸腫瘤學術會議,國防醫學院)
  63. Yeh CT, Yeh CF, Chang CK,Yao CJ, Yan JL, Li CH, Chuang SE and Lai GM. Extracts of Cultivated Antrodia Camphorata Fruiting Body Eradicate Cancer Stem-Like Cells in Hepatocellular Carcinoma Cell Lines. The 13th Taiwan Joint Cancer Conference. May 3-4, 2008. (第十三屆台灣癌症聯合學術年會暨第六屆海峽兩岸腫瘤學術會議,國防醫學院)
  64. Yeh CT, Yao CJ, Chang CK, Yeh CF, Li CH, Yan JL, Chuang SE and Lai GM. Human Urine Extract CDA-2-Induced Epigenetic Modification and Elimination of Cancer Stem-Like “Side Population” Cells in Hepatoma Cell Lines. The 13th Taiwan Joint Cancer Conference. May 3-4, 2008. (第十三屆台灣癌症聯合學術年會暨第六屆海峽兩岸腫瘤學術會議,國防醫學院)
  65. Lai GM, Yao CJ, Yeh CT, Yeh CF, Chang CK, Yan JL, Li CH and Chuang SE. Multiple Molecular Targeting Anticancer Effects and Eradication of Cancer Stem-like Cells by Active Fraction of Solid-cultivated Taiwanofungus Camphoratus. 2008 International Chinese Herbal Medicine Seminar at Pingtung Agricultural Biotechnology Park. June 12, 2008.
  66. Yeh CT, Yao CJ, Chang CK, Yeh CF, Li CH, Yan JL, Chuang SE, and Lai GM. Elimination and Epigenetic Modification of Cancer Stem-Like “Side Population” Cells in Hepatoma Cell Lines by Human Urine Extract CDA-2. 2008 NHRI Research Day. Miaoli, Taiwan. August 22, 2008.
  67. Yan JL, Li CH, Lu HJ, Yao CJ, Yeh CF, Yeh CT, Chuang SE, Kan LS, and Lai GM. Purification and Characterization of Anticancer Active Triterpenoids from Fruiting Body of Taiwanofungus Camphoratus. 2008 NHRI Research Day. Miaoli, Taiwan. August 22, 2008.
  68. Hong CC, Lay JD, Huang JS, Cheng AL, Tang JL, Lin MT, Lai GM, and Chuang SE*. The Role of Tyrosine Kinase AXL in Acute Myeloid Leukemia Drug Resistance. 2008 NHRI Research Day. Miaoli, Taiwan. August 22, 2008.
  69. Huang JS, Hong CC, Lay JD, Cho CY, and Chuang SE*. Oxidative Stress Enhances AXL-Mediated Migration Through Akt1. 2008 NHRI Research Day. Miaoli, Taiwan. August 22, 2008.
  70. Yan MD, Lin YW, Chang PY, and Chuang SE*. Identification and Characterization of Alternative Splice Forms of FAS in Human Hepatocellular Carcinomas. 2008 NHRI Research Day. Miaoli, Taiwan. August 22, 2008.
  71. Yan KH, Yao CJ, and Chuang SE*. The Synergistic Anticancer Effect of Troglitazone Combined with Aspirin in Lung Cancer Cells. 2008 NHRI Research Day. Miaoli, Taiwan. August 22, 2008.
  72. Yeh CT, Yao CJ, Chang CK, Yeh CF, Yan JL, Li CH, Chuang SE, and Lai GM. Elimination of Cancer Stem-Like cells in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer Cell Lines by Chinese Medicine. The 7th Meeting of the Consortium for Globalization of Chinese Medicine (第七屆中藥全球化聯盟研討會), August 28-30, 2008, Taipei (National Yang-Ming University, National Research Institute of Chinese Medicine).
  73. Yeh CY, Yao CJ, Chang CK, Yeh CF, Li CH, Yan JL, Chuang SE, and Lai GM. Elimination and epigenetic modification of cancer stem-like “side population” cells in hepatoma cell lines by human urine extract CDA-2. The 2008 AACR Annual Meeting in San Diego, USA. April 12-16, 2008 (Abstract No. 4592)
  74. Huang JS, Hong CC, Lai JD, Cho CY, and Chuang SE*. Oxidative Stress Enhances AXL-mediated Migration through Akt1. AACR special conference on “Targeting the PI3-Kinase Pathway in Cancer”. November 11 – 14, 2008. Cambridge, Massachusetts, USA.
  75. Yeh CT, Yeh CF, Yao CJ, Chuang SE, and Lai GM. Effects of arsenic trioxide on the imatinib sensitivity of CD34+ cells and c-Kit expression of CD34+/CD38- cells in K562 chronic myelocytic leukemia. The 2009 AACR Annual Meeting in Denver, USA. April 18-22, 2009 (Abstract No. 1078) (NICR, NHRI and Cancer Center of Wan-Fang Hospital, Taipei Medical University, Taipei, Taiwan)
  76. Yao CJ, Yeh CT, Yeh CF, Chang CK, Li CH, Yan JL, Chuang SE, and Lai GM. Active component isolated from human urine extract (CDA-2) has activities of eliminating cancer stem-like cells and inhibition of epithelial mesenchymal transition. The 2009 AACR Annual Meeting in Denver, USA. April 18-22, 2009 (Abstract No. 5461)
  77. Lai GM, Yao CJ, Yeh CT, Yeh CF, Chang CK, Yan JL, Li CH, and Chuang SE. Active fraction of Taiwanofungus camphoratus (HS7) exerted anticancer effects through multiple molecular targeting and elimination of cancer stem-like cells in lung cancer and hepatoma cells. The 2009 AACR Annual Meeting in Denver, USA. April 18-22, 2009 (Abstract No. 5475)
  78. 葉淇臺, 莊雙恩, 賴基銘 etc:三氧化二砷加強 Imatinib對 K562慢性骨髓性血癌細胞株中具看細胞特性的CD34+/CD38- 與CD34+/CD38+細胞的抑制作用。The 14th Taiwan Joint Cancer Conference. May 2-3, 2009. (第十四屆台灣癌症聯合學術年會,國防醫學院), Abstract A1-67。
  79. 姚智榮, 莊雙恩, 賴基銘 etc:研究人尿萃取物活性成分P23.2在消除類癌幹細胞與抑制上皮細胞間質轉化的作用。The 14th Taiwan Joint Cancer Conference. May 2-3, 2009. (第十四屆台灣癌症聯合學術年會,國防醫學院), Abstract A1-66。
Share Button

Comments are closed.